Newron Pharmaceuticals S.p.A. (FRA:NP5)
Germany flag Germany · Delayed Price · Currency is EUR
11.26
+0.06 (0.54%)
At close: Sep 26, 2025

Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of €230.85 million as of September 30, 2025. Its market cap has increased by 41.50% in one year.

Market Cap
230.85M
Enterprise Value
240.21M
Revenue
59.88M
Ranking
n/a
PE Ratio
9.11
Stock Price
€11.26

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 194.15M to 230.85M, an increase of 18.90%. That is a compound annual growth rate of 0.92%.

History

DateMarket Cap% Change
Sep 29, 2025234.01M26.45%
Dec 30, 2024185.06M94.99%
Dec 29, 202394.91M239.07%
Dec 30, 202227.99M0.21%
Dec 30, 202127.93M-20.96%
Dec 30, 202035.34M-66.13%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition